Korro Bio (KRRO) FCF Margin (2019 - 2025)
Korro Bio's (KRRO) quarterly FCF Margin came in at 1376.63% in Q4 2025, down 98266.0% on a YoY basis from N/an in Q4 2024, and up 13.53% quarter-over-quarter from 1592.11% in Q3 2025.
Powered by 
Analysis
Korro Bio (KRRO) FCF Margin (2019 - 2025) Analysis & Trends
Korro Bio (KRRO) has reported FCF Margin for 5 consecutive years, with 1376.63% the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin fell 98266.0% year-over-year to 1376.63%; the trailing twelve-month figure through Jun 2026 stood at 2865.87% (down 168996.0% YoY), and the FY2025 full-year result was 1237.16%, up 219640.0% from the prior year.
- FCF Margin advanced to 1376.63% in Q4 2025 per KRRO's latest filing, from 1592.11% in the prior quarter.
- Across five years, FCF Margin topped out at 195.65% in Q2 2021 and bottomed at 1592.11% in Q3 2025.
- Historically, FCF Margin has averaged 919.25% across 3 years, with a median of 963.57% in 2025.
- The sharpest annual moves came in 2021 and 2025: FCF Margin sank 6458 bps in 2021, then tumbled 98266 bps in 2025.
- Over 3 years, FCF Margin stood at 195.65% in 2021, then sank by 101 bps to 393.97% in 2024, then slumped by 249 bps to 1376.63% in 2025.
- According to Business Quant data, FCF Margin over the past three periods registered 1376.63%, 1592.11%, and 1326.58% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.69 Bn | 192.70 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 179.87 Bn | 176.70 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 81.70 Bn | 73.71 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.28 Bn | 49.14 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 33.02 Bn | 29.71 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 29.27 Bn | 29.27 Bn | 1.16 Mn | -18,629.40% |
| 10 | Korro Bio | 231.15 Mn | 116.12 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1,376.63% |
| Sep 30, 2025 | -1,592.11% |
| Jun 30, 2025 | -1,326.58% |
| Mar 31, 2025 | -963.57% |
| Dec 31, 2024 | -393.97% |
| Jun 30, 2021 | -195.65% |
| Mar 31, 2021 | -586.24% |
| Dec 31, 2020 | -193.48% |
| Sep 30, 2020 | -104.30% |
| Jun 30, 2020 | -131.07% |
| Mar 31, 2020 | -133.62% |
| Dec 31, 2019 | -640.54% |
| Sep 30, 2019 | 307.06% |